GlassScriptPrepare for your visit
Irma Y Castro
Family Medicine · Fresno, CA · NPI 1285652669
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$15,201.81
in general payments reported to CMS, 2019-2025 · $1,722 in 2025
The $1,722 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Who reported paying
General payments only, top 6 by amount.
- Novo Nordisk INC $1,890.94
- Glaxosmithkline, LLC. $1,725.06
- Lilly USA, LLC $1,459.17
- Astrazeneca Pharmaceuticals LP $1,366.90
- Amgen INC. $1,168.82
- Boehringer Ingelheim Pharmaceuticals, INC. $866.87
Drugs and devices associated with these payments
Mounjaro Jardiance Repatha Airsupra Ozempic Kerendia Rybelsus Trelegy Ellipta Prolia Recorlev Vraylar Wegovy
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Irma Castro listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/58552/irma-y-castro